Hazard Rate
Prediction Intervals
Steps in Outbreak Investigation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Receiver Operating Characteristic Plot
Relative Risk
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 11, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Giovanni Tripepi1, Georg Heinze, Kitty J Jager
1CNR-IBIM, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Calabria, Italy.
This study explains how to develop and validate risk prediction models for diseases like coronary heart disease (CHD) and chronic kidney disease (CKD). Proper validation ensures accurate prognostication for better clinical decision-making.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: